Works matching IS 13657852 AND DT 2012 AND VI 15 AND IP 3

Results: 16

Advanced prostate cancer: reinforcing the strings between inflammation and the metastatic behavior.
Published in:
Prostate Cancer & Prostatic Diseases, 2012, v. 15, n. 3, p. 213, doi. 10.1038/pcan.2011.64
By:
- Gueron, G;
- De Siervi, A;
- Vazquez, E
Publication type:
Article
Long-term follow-up of prostate cancer patients treated with vaccine and definitive radiation therapy.
Published in:
Prostate Cancer & Prostatic Diseases, 2012, v. 15, n. 3, p. 289, doi. 10.1038/pcan.2012.7
By:
- Kamrava, M;
- Kesarwala, A H;
- Madan, R A;
- Lita, E;
- Kaushal, A;
- Tsang, K-Y;
- Poole, D J;
- Steinberg, S M;
- Ferrara, T;
- Dahut, W;
- Schlom, J;
- Gulley, J L
Publication type:
Article
Role of 5α-reductase inhibitors in benign prostatic diseases.
Published in:
Prostate Cancer & Prostatic Diseases, 2012, v. 15, n. 3, p. 222, doi. 10.1038/pcan.2012.1
By:
- Azzouni, F;
- Mohler, J
Publication type:
Article
Zoledronic acid influences growth, migration and invasive activity of prostate cancer cells in vitro.
Published in:
Prostate Cancer & Prostatic Diseases, 2012, v. 15, n. 3, p. 250, doi. 10.1038/pcan.2012.9
By:
- Mani, J;
- Vallo, S;
- Barth, K;
- Makarević, J;
- Juengel, E;
- Bartsch, G;
- Wiesner, C;
- Haferkamp, A;
- Blaheta, R A
Publication type:
Article
Role of denosumab in prostate cancer.
Published in:
Prostate Cancer & Prostatic Diseases, 2012, v. 15, n. 3, p. 231, doi. 10.1038/pcan.2012.2
By:
- Helo, S;
- Manger, J P;
- Krupski, T L
Publication type:
Article
Responder analysis of the effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer.
Published in:
Prostate Cancer & Prostatic Diseases, 2012, v. 15, n. 3, p. 308, doi. 10.1038/pcan.2012.18
By:
- Egerdie, R B;
- Saad, F;
- Smith, M R;
- Tammela, T L J;
- Heracek, J;
- Sieber, P;
- Ke, C;
- Leder, B;
- Dansey, R;
- Goessl, C
Publication type:
Article
Complete high-intensity focused ultrasound in prostate cancer: outcome from the @-Registry.
Published in:
Prostate Cancer & Prostatic Diseases, 2012, v. 15, n. 3, p. 256, doi. 10.1038/pcan.2012.10
By:
- Blana, A;
- Robertson, C N;
- Brown, S C W;
- Chaussy, C;
- Crouzet, S;
- Gelet, A;
- Conti, G N;
- Ganzer, R;
- Pasticier, G;
- Thuroff, S;
- Ward, J F
Publication type:
Article
A comprehensive review of incidence and survival in patients with rare histological variants of prostate cancer in the United States from 1973 to 2008.
Published in:
Prostate Cancer & Prostatic Diseases, 2012, v. 15, n. 3, p. 283, doi. 10.1038/pcan.2012.4
By:
- Marcus, D M;
- Goodman, M;
- Jani, A B;
- Osunkoya, A O;
- Rossi, P J
Publication type:
Article
Long-term quality of life in disadvantaged men with prostate cancer on androgen-deprivation therapy.
Published in:
Prostate Cancer & Prostatic Diseases, 2012, v. 15, n. 3, p. 237, doi. 10.1038/pcan.2011.71
By:
- Sevilla, C;
- Maliski, S L;
- Kwan, L;
- Connor, S E;
- Litwin, M S
Publication type:
Article
Testosterone recovery in the off-treatment time in prostate cancer patients undergoing intermittent androgen deprivation therapy.
Published in:
Prostate Cancer & Prostatic Diseases, 2012, v. 15, n. 3, p. 296, doi. 10.1038/pcan.2012.12
By:
- Tunn, U W;
- Canepa, G;
- Kochanowsky, A;
- Kienle, E
Publication type:
Article
Targeted therapy with fatty acid synthase inhibitors in a human prostate carcinoma LNCaP/tk-luc-bearing animal model.
Published in:
Prostate Cancer & Prostatic Diseases, 2012, v. 15, n. 3, p. 260, doi. 10.1038/pcan.2012.15
By:
- Chen, H-W;
- Chang, Y-F;
- Chuang, H-Y;
- Tai, W-T;
- Hwang, J-J
Publication type:
Article
The prevalence of lower urinary tract symptoms and treatment-seeking behaviour in males over 40 years in Singapore: a community-based study.
Published in:
Prostate Cancer & Prostatic Diseases, 2012, v. 15, n. 3, p. 273, doi. 10.1038/pcan.2011.69
By:
- Chong, C;
- Fong, L;
- Lai, R;
- Lau, W K O;
- Hartmann, M;
- Chia, S E
Publication type:
Article
MTHFR polymorphism and the risk of prostate cancer: a meta-analysis of case-control studies.
Published in:
Prostate Cancer & Prostatic Diseases, 2012, v. 15, n. 3, p. 244, doi. 10.1038/pcan.2012.5
By:
- Li, X-L;
- Xu, J-H
Publication type:
Article
Body mass index and risk of BPH: a meta-analysis.
Published in:
Prostate Cancer & Prostatic Diseases, 2012, v. 15, n. 3, p. 265, doi. 10.1038/pcan.2011.65
By:
- Wang, S;
- Mao, Q;
- Lin, Y;
- Wu, J;
- Wang, X;
- Zheng, X;
- Xie, L
Publication type:
Article
Toxicity in patients receiving adjuvant docetaxel + hormonal treatment after radical radiotherapy for intermediate or high-risk prostate cancer: a preplanned safety report of the SPCG-13 trial.
Published in:
Prostate Cancer & Prostatic Diseases, 2012, v. 15, n. 3, p. 303, doi. 10.1038/pcan.2012.13
By:
- Kellokumpu-Lehtinen, P-L;
- Hjälm-Eriksson, M;
- Thellenberg-Karlsson, C;
- Åström, L;
- Franzen, L;
- Marttila, T;
- Seke, M;
- Taalikka, M;
- Ginman, C
Publication type:
Article
Assessing prostate cancer growth with citrate measured by intact tissue proton magnetic resonance spectroscopy.
Published in:
Prostate Cancer & Prostatic Diseases, 2012, v. 15, n. 3, p. 278, doi. 10.1038/pcan.2011.70
By:
- Dittrich, R;
- Kurth, J;
- Decelle, E A;
- DeFeo, E M;
- Taupitz, M;
- Wu, S;
- Wu, C-l;
- McDougal, W S;
- Cheng, L L
Publication type:
Article